| Name | Age | Overall rating | Potential | Team & Contract | Value | Wage | Total stats | ||
|---|---|---|---|---|---|---|---|---|---|
|
G. Gineitis | 20 | 65 +3 | 80 +1 |
2022 ~ 2026
| €1.7M | €7K | 1735 | |
|
|
G. Gineitis | 20 | 65 +3 | 80 +1 |
2022 ~ 2026
| €1.7M | €7K | 1735 | |
|
|
G. Gineitis | 20 | 64 +2 | 80 +1 |
2022 ~ 2026
| €1.5M | €7K | 1720 | |
|
|
G. Gineitis | 20 | 79 +17 | 79 |
2022 ~ 2026
| €19.5M | €37K | 2196 | |
|
|
G. Gineitis | 20 | 76 +14 | 81 |
2022 ~ 2026
| €11M | €29K | 2079 | |
|
|
G. Gineitis | 20 | 79 +17 | 98 +17 |
2022 ~ 2026
| €46M | €37K | 2140 | |
|
|
G. Gineitis | 20 | 66 +4 | 85 +4 |
2022 ~ 2026
| €2.2M | €9K | 1783 | |
|
|
G. Gineitis | 20 | 99 +37 | 99 +18 |
2022 ~ 2026
| €327.5M | €340K | 2739 | |
|
|
G. Gineitis FUTURE STARS | 20 | 89 +27 | 99 +18 |
2022 ~ 2026
| €225.5M | €86K | 2414 | |
|
|
G. Gineitis | 19 | 82 +20 | 82 +1 |
2022 ~ 2026
| €33M | €34K | 2200 | |
|
|
Goatneitis | 19 | 99 +37 | 99 +18 |
2022 ~ 2026
| €317.5M | €260K | 3267 | |
|
23 G. Gineitis | 19 | 74 +13 | 82 +2 |
Jun 30, 2026 On loan
| €9M | €15K | 1823 | |
|
|
G. Gineitis | 19 | 75 +14 | 84 +4 |
2022 ~ 2026
| €11.5M | €18K | 1898 | |
|
|
G. Gineitis | 19 | 80 +19 | 80 |
2022 ~ 2026
| €23M | €30K | 1667 | |
|
|
G. Gineitis | 19 | 80 +19 | 80 |
2022 ~ 2026
| €23M | €30K | 1667 | |
|
|
G. Gineitis | 19 | 66 +5 | 78 -2 |
2022 ~ 2026
| €2M | €7K | 1658 | |
|
|
G. Gineitis | 19 | 63 +2 | 81 +1 |
2022 ~ 2026
| €1.2M | €5K | 1667 | |
|
|
G. Gineitis | 19 | 63 +2 | 81 +1 |
 Lithuania
Free
| €0 | €0 | 1667 | |
|
|
G. Gineitis | 19 | 62 +1 | 81 +1 |
2022 ~ 2026
| €1M | €4K | 1667 | |
|
|
G. Gineitis | 19 | 66 +5 | 80 |
2022 ~ 2026
| €2M | €7K | 1703 | |
|
|
G. Gineitis | 19 | 70 +9 | 82 +2 |
2022 ~ 2026
| €3.8M | €12K | 1862 | |
|
|
G. Gineitis | 19 | 69 +8 | 81 +1 |
2022 ~ 2026
| €3.3M | €11K | 1739 | |
|
|
G. Gineitis | 24 | 80 +19 | 82 +2 |
2022 ~ 2026
| €27M | €46K | 1895 | |
|
|
G. Gineitis | 19 | 65 +4 | 83 +3 |
2022 ~ 2026
| €1.8M | €6K | 1792 | |
|
|
G. Gineitis | 19 | 66 +5 | 80 |
2022 ~ 2026
| €2M | €7K | 1703 | |
|
|
G. Gineitis | 19 | 80 +19 | 82 +2 |
2022 ~ 2026
| €26M | €30K | 1895 | |
|
|
G. Gineitis | 19 | 62 +1 | 80 |
2022 ~ 2026
| €1M | €4K | 1655 | |
|
|
G. Gineitis | 19 | 80 +19 | 82 +2 |
2022 ~ 2026
| €26M | €30K | 1895 | |
|
|
G. Gineitis | 19 | 65 +4 | 81 +1 |
2022 ~ 2026
| €1.8M | €6K | 1734 | |
|
|
G. Gineitis | 19 | 80 +19 | 80 |
2022 ~ 2026
| €23M | €30K | 2217 | |
|
|
G. Gineitis | 19 | 68 +7 | 86 +6 |
2022 ~ 2026
| €3.1M | €9K | 1872 | |
|
|
G. Gineitis | 19 | 64 +3 | 80 |
2022 ~ 2026
| €1.5M | €5K | 1679 | |
|
|
G. Gineitis | 19 | 80 +19 | 82 +2 |
2022 ~ 2026
| €26M | €30K | 1895 | |
|
|
G. Gineitis | 19 | 83 +22 | 83 +3 |
2022 ~ 2026
| €35M | €32K | 2031 | |
|
|
G. Gineitis | 19 | 69 +8 | 80 |
2022 ~ 2026
| €3M | €11K | 1794 | |
|
|
G. Gineitis | 19 | 80 +19 | 80 |
2022 ~ 2026
| €23M | €30K | 1871 | |
|
|
G. Gineitis | 19 | 68 +7 | 87 +7 |
Jul 1, 2024 On loan
| €3.1M | €3K | 1781 | |
|
|
G. Gineitis | 19 | 80 +19 | 80 |
2022 ~ 2026
| €23M | €30K | 1871 | |
|
|
G. Gineitis | 19 | 64 +3 | 80 |
2022 ~ 2026
| €1.5M | €5K | 1710 | |
|
|
G. Gineitis | 19 | 74 +13 | 83 +3 |
2022 ~ 2026
| €9M | €20K | 2025 | |
|
|
G. Gineitis | 19 | 64 +3 | 80 |
2022 ~ 2026
| €1.5M | €5K | 1679 | |
|
|
23 G. Gineitis | 19 | 65 +4 | 80 |
2022 ~ 2026
| €1.7M | €6K | 1719 | |
|
|
23 G. Gineitis | 19 | 78 +17 | 97 +17 |
2022 ~ 2026
| €36M | €26K | 2087 | |
|
|
23 G. Gineitis | 19 | 66 +5 | 80 |
2022 ~ 2026
| €2M | €7K | 1703 | |
|
|
23 G. Gineitis | 19 | 80 +19 | 80 |
2022 ~ 2026
| €23M | €30K | 2197 | |
|
|
23 2032 | 19 | 80 +19 | 81 +1 |
2022 ~ 2026
| €24.5M | €42K | 2086 | |
|
|
23 2029 | 19 | 77 +16 | 80 |
2022 ~ 2026
| €13.5M | €33K | 2032 | |
|
|
23 L. Gineitis | 19 | 64 +3 | 82 +2 |
2022 ~ 2026
| €1.5M | €5K | 1795 | |
|
|
23 G. Gineitis | 19 | 78 +17 | 84 +4 |
2022 ~ 2026
| €21M | €26K | 1847 | |
|
|
23 G. Gineitis | 19 | 65 +4 | 81 +1 |
2022 ~ 2026
| €1.8M | €6K | 1743 | |
|
23 G. Gineitis | 19 | 80 +19 | 80 |
2022 ~ 2026
| €23M | €30K | 1871 | |
|
|
23 G. Gineitis | 19 | 83 +22 | 99 +19 |
2022 ~ 2026
| €93.5M | €38K | 2227 | |
|
|
23 G. Gineitis | 21 | 85 +24 | 92 +12 |
2022 ~ 2026
| €109M | €59K | 1931 | |
|
|
23 G. Gineitis | 28 | 80 +19 | 80 |
2022 ~ 2026
| €21M | €55K | 1667 | |
|
|
23 G. Gineitis | 19 | 81 +20 | 81 +1 |
2022 ~ 2026
| €28M | €32K | 2147 | |
|
|
23 G. Gineitis | 19 | 70 +9 | 80 |
2022 ~ 2030
| €3.4M | €12K | 1869 | |
|
|
23 G. Gineitis | 19 | 63 +2 | 81 +1 |
2022 ~ 2026
| €1.2M | €5K | 1667 | |
|
23 G. Gineitis | 18 | 63 +2 | 80 |
2022 ~ 2025
| €1.2M | €3K | 1667 | |
|
|
23 G. Gineitis | 18 | 80 +19 | 89 +9 |
2022 ~ 2026
| €44.5M | €18K | 1871 | |
|
|
23 G. Gineitis TOTS | 18 | 89 +28 | 99 +19 |
2022 ~ 2026
| €216.5M | €41K | 2358 |